-
Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
Quest Diagnostics (NYSE:DGX) reported first-quarter 2026 results that absorption said reflected broad-based integrated growth, improving productivity from automation and artificial intelligence, and contributions from large collaborations including Fresenius Medical Care and Corewell Health. The institution besides raised its full-year gross and net guidance pursuing the quarter.
Chairman, President and CEO Jim Davis said Quest delivered “strong archetypal 4th performance” arsenic request accrued for objective innovations, expansions into caller objective areas, and collaborations with healthcare and user wellness organizations. Davis said gross grew much than 9% “almost wholly from integrated gross growth,” portion adjusted diluted EPS roseate astir 13%.
→ $39 Trillion Debt Signal: 3 TIPS ETFs to Hedge Persistent Inflation
-
LifeMD Shares Come Back to Life connected GLP-1 Business Growth
CFO Sam Samad reported consolidated gross of $2.9 billion, up 9.2% twelvemonth implicit year, with consolidated integrated gross up 9%.
Diagnostic Information Services gross accrued 9.4% versus the anterior year, which Samad attributed to beardown integrated maturation crossed physician, infirmary and user channels. Reported operating income was $399 million, oregon 13.8% of revenue, compared with $346 million, oregon 13% of revenue, a twelvemonth earlier. On an adjusted basis, operating income was $447 million, oregon 15.4% of revenue, compared with $406 million, oregon 15.3% of revenue, past year.
→ Could These 3 New-to-Market Quantum Computing Firms Threaten D-Wave?
-
Exact Sciences Serves Investors Exactly What They Wished For
Quest posted reported EPS of $2.24 compared with $1.94 a twelvemonth ago; adjusted EPS was $2.50 compared with $2.21. Samad said adjusted EPS maturation was driven mostly by integrated gross growth, accrued productivity, and little involvement expense, partially offset by wage increases and upwind impacts.
Cash from operations was $278 million, down from $314 cardinal successful the prior-year play owed to timing of receipts and disbursements and higher bonus payments, partially offset by higher operating income.
→ Nebius Group Is Trading Near All-Time Highs, Here's How Far It Has Come
Based connected first-quarter performance, Samad said Quest raised its full-year 2026 guidance and present expects:
-
Revenue: $11.78 cardinal to $11.9 cardinal (6.8% to 7.8% growth)
-
Reported EPS: $9.58 to $9.78
-
Adjusted EPS: $10.63 to $10.83
-
Cash from operations: astir $1.75 billion
-
Capital expenditures: astir $550 million

1 week ago
11





English (CA) ·
English (US) ·
Spanish (MX) ·